P2.07. Genomic Subtypes of EGFR-Mutant NSCLC and Real-World Progression-Free Survival (rwPFS) with Immunotherapy (IO) - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Joseph Bodor
Meta Tag
Speaker Joseph Bodor
Topic Metastatic NSCLC: Immunotherapy - Retrospective
genomic subtypes
EGFR-mutant non-small cell lung cancer
real-world data
Flatiron Health-Foundation Medicine
clinicogenomic database
PD-L1 expression
tumor mutational burden
progression-free survival
IO resistance
Powered By